X4 Pharmaceuticals Inc (NASDAQ:XFOR)
| 0.9997 BATS BZX Real-Time Price As of 3:20pm ET |  -0.0903 / -8.28%Today’s Change | 0.65 Today|||52-Week Range 2.58 | +0.67% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 3.5M | 0.00 | 0.00 | |
| Depreciation And Amortization | 36.0K | 34.0K | 20.0K | 24.0K | ||
| Operating Expenses | Gross Income | -36.0K | -- | -20.0K | -24.0K | |
| General Expenses | 12.4M | 9.8M | 10.4M | 13.4M | ||
| Research And Development | 9.6M | 4.3M | 5.7M | 8.9M | ||
| Total Operating Expenses | 12.4M | 9.9M | 10.4M | 13.4M | ||
| Non-Operating Expenses | Operating Income | -12.4M | -6.4M | -10.4M | -13.4M | |
| Extraordinary Charge | -400.0K | -3.1M | -105.0K | 0.00 | ||
| Interest Expense On Debt | 259.0K | 254.0K | 399.0K | 512.0K | ||
| Other Expenses | -6.0K | -6.0K | 0.00 | 149.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -10.9M | -9.4M | -10.9M | -13.4M | |
| Preferred Dividend | 0.00 | 0.00 | -592.0K | 0.00 | ||
| Net Income | -10.9M | -9.4M | -10.9M | -13.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 397.7K | -- | 1.7M | 13.2M | |
| Shares To Calculate EPS Diluted | 397.7K | -- | 1.7M | 13.2M | ||
| Earnings Per Share | EPS | -$27.36 | -- | -$6.67 | -$1.02 | |
| EPS Diluted | -$27.41 | -- | -$6.67 | -$1.02 | ||
